Can a weekly obesity pill move beyond GLP-1? Verdiva Bio puts oral amylin candidate VRB-103 into human testing
Verdiva Bio has begun Phase 1 testing of weekly oral amylin candidate VRB-103. See what the trial can prove and what remains uncertain.
Pharma & Biotech